Rigel Pharmaceuticals Inc
RIGL· Nasdaq
RIGLRigel Pharmaceuticals Inc
Released May 2, 2017, after the close
10-Q filed May 2, 2017, 32 days after period end · 0001558370-17-003254
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q1 2017 | Q1 2016 | Q1 2015 | Q1 2014 |
|---|---|---|---|---|
| Revenue | $3.58M | — | — | — |
| Net Income | -$15.31M | — | — | — |
| EPS Diluted | -$0.13 | -$0.19 |
Rigel Pharmaceuticals Inc · CIK 1034842 · Engraved from SEC EDGAR
| -$0.21 |
| -$0.25 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
